Role of Rajnidaaru eye drops and Rasayan Churna in the management of Shushkaakshipaka (Dry eye syndrome) - An open label double arm randomized clinical trialâ??

All india Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Age group less than 18 and more than 60 years.
•2.Severe cases of dry eye syndrome with complications like perforated corneal ulcer, Uveitis, Glaucoma.
•3.Allergic eye disease i.e. vernal keratoconjunctivitis, Giant papillary conjunctivitis.
•4.Non specific topical beta blocker users.
•5.Inflammatory conditions like acute conjunctivitis.
•6.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication such as antispasmodic drugs like Atropine that may adversely affect the outcome of the study.
•7.Patients suffering from major systemic illness necessitating long term drug treatment i.e. Psycho-epileptic drug users.
•8.H/o hypersensitivity to the trial drug or any of its ingredients.
•9.Persistent Contact Lens Users.

发起方